Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-25 @ 3:20 AM
Study NCT ID:
NCT02797704
Status:
TERMINATED
Last Update Posted:
2019-09-16
First Post:
2016-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Sponsor:
Rabin Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0134-16-RMC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None